Role of vasoactive intestinal peptide in the progression of osteoarthritis through bone sclerosis and angiogenesis in subchondral bone

[1] Creamer P, Hochberg MC. Osteoarthritis. Lancet (London, Engl) 1997 Aug

16;350(9076):503e8.

[2] Madry H, van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral

bone. Knee Surg Sports Traumatol Arthrosc 2010 Apr;18(4):419e33.

[3] Intema F, Hazewinkel HA, Gouwens D, Bijlsma JW, Weinans H, Lafeber FP,

Mastbergen SC. In early OA, thinning of the subchondral plate is directly

related to cartilage damage: results from a canine ACLT-meniscectomy model.

Osteoarthr Cartil 2010 May;18(5):691e8.

[4] Yoo YM, Kwag JH, Kim KH, Kim CH. Effects of neuropeptides and mechanical

loading on bone cell resorption in vitro. Int J Mol Sci 2014 Apr 8;15(4):

5874e83.

[5] Yu X, Lv L, Zhang J, Zhang T, Xiao C, Li S. Expression of neuropeptides and bone

remodeling-related factors during periodontal tissue regeneration in denervated rats. J Mol Histol 2015 Apr;46(2):195e203.

[6] Liu D, Zhao CQ, Li H, Jiang SD, Jiang LS, Dai LY. Effects of spinal cord injury and

hindlimb immobilization on sublesional and supralesional bones in young

growing rats. Bone 2008 Jul;43(1):119e25.

[7] Lerner UH, Persson E. Osteotropic effects by the neuropeptides calcitonin

gene-related peptide, substance P and vasoactive intestinal peptide.

J Musculoskelet Neuronal Interact 2008 Apr-Jun;8(2):154e65.

[8] Jiang W, Gao SG, Chen XG, Xu XC, Xu M, Luo W, Tu M, Zhang FJ, Zeng C, Lei GH.

Expression of synovial fluid and articular cartilage VIP in human osteoarthritic

knee: a new indicator of disease severity? Clin Biochem 2012 Dec;45(18):

1607e12.

[9] Jiang W, Wang H, Li YS, Luo W. Role of vasoactive intestinal peptide in osteoarthritis. J Biomed Sci 2016 Aug 23;23(1):63.

[10] Persson E, Lerner UH. The neuropeptide VIP regulates the expression of

osteoclastogenic factors in osteoblasts. J Cell Biochem 2011 Dec;112(12):

3732e41.

[11] Mukohyama H, Ransjo M, Taniguchi H, Ohyama T, Lerner UH. The inhibitory

effects of vasoactive intestinal peptide and pituitary adenylate cyclaseactivating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. Biochem

Biophys Res Commun 2000 Apr 29;271(1):158e63.

[12] Xiao J, Yu W, Wang X, Wang B, Chen J, Liu Y, Li Z. Correlation between neuropeptide distribution, cancellous bone microstructure and joint pain in

postmenopausal women with osteoarthritis and osteoporosis. Neuropeptides

2016 Apr;56:97e104.

[13] Botter SM, van Osch GJ, Clockaerts S, Waarsing JH, Weinans H, van

Leeuwen JP. Osteoarthritis induction leads to early and temporal subchondral

plate porosity in the tibial plateau of mice: an in vivo microfocal computed

tomography study. Arthritis Rheum 2011 Sep;63(9):2690e9.

Please cite this article as: Kanemitsu M et al., Role of vasoactive intestinal peptide in the progression of osteoarthritis through bone sclerosis and

angiogenesis in subchondral bone, Journal of Orthopaedic Science, https://doi.org/10.1016/j.jos.2019.11.010

10

M. Kanemitsu et al. / Journal of Orthopaedic Science xxx (xxxx) xxx

[14] Sample SJ, Hao Z, Wilson AP, Muir P. Role of calcitonin gene-related peptide in

bone repair after cyclic fatigue loading. PLoS One 2011 June 9;6(6):e20386.

[15] Ogino S, Sasho T, Nakagawa K, Suzuki M, Yamaguchi S, Higashi M,

Takahashi K, Moriya H. Detection of pain-related molecules in the subchondral bone of osteoarthritic knees. Clin Rheumatol 2009 Dec;28(12):

1395e402.

[16] Nakasa T, Ishikawa M, Takada T, Miyaki S, Ochi M. Attenuation of cartilage

degeneration by calcitonin gene-related paptide receptor antagonist via inhibition of subchondral bone sclerosis in osteoarthritis mice. J Orthop Res

2016 Jul;34(7):1177e84.

[17] Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial

meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr

Cartil 2007 Sep;15(9):1061e9.

[18] Vu JP, Million M, Larauche M, Luong L, Norris J, Waschek JA, Pothoulakis C,

Pisegna JR, Germano PM. Inhibition of vasoactive intestinal polypeptide (VIP)

induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice.

J Mol Neurosci 2014 Jan;52(1):37e47.

[19] Lacourt M, Gao C, Li A, Girard C, Beauchamp G, Henderson JE, Laverty S.

Relationship between cartilage and subchondral bone lesions in repetitive

impact trauma-induced equine osteoarthritis. Osteoarthr Cartil 2012

Jun;20(6):572e83.

[20] Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D,

van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil 2006 Jan;14(1):13e29.

[21] Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology

initiative - recommendations for histological assessments of osteoarthritis in the

mouse. Osteoarthr Cartil 2010 Oct;18(Suppl 3):S17e23.

[22] Takada T, Miyaki S, Ishitobi H, Hirai Y, Nakasa T, Igarashi K, et al. Bach1

deficiency reduces severity of osteoarthritis through upregulation of heme

oxygenase-1. Arthritis Res Ther 2015 Oct 13;17(1):285. https://doi.org/

10.1186/s13075-015-0792-1.

[23] Zemmyo M, Meharra EJ, Kuhn K, Creighton-Achermann L, Lotz M. Accelerated,

aging-dependent development of osteoarthritis in alpha1 integrin-deficient

mice. Arthritis Rheum 2003 Oct;48(10):2873e80.

[24] Gholobova D, Decroix L, Van Muylder V, Desender L, Gerard M, Carpentier G,

Vandenburgh H, Thorrez L. Endothelial network formation within human tissueengineered skeletal muscle. Tissue Eng Part A 2015 Oct;21(19e20):2548e58.

[25] Stanton H, Golub SB, Rogerson FM, Last K, Little CB, Fosang AJ. Investigating

ADAMTS-mediated aggrecanolysis in mouse cartilage. Nat Protoc 2011

Mar;6(3):388e404.

[26] Ransjo M, Lie A, Mukohyama H, Lundberg P, Lerner UH. Microisolated mouse

osteoclasts express VIP-1 and PACAP receptors. Biochem Biophys Res Commun 2000 Aug 2;274(2):400e4.

[27] Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone 2012

Aug;51(2):204e11.

[28] Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, et al. Subchondral bone in

osteoarthritis: insight into risk factors and microstructural changes. Arthritis

Res Ther 2013 Dec 9;15(6):223.

[29] Fang H, Huang L, Welch I, Norley C, Holdsworth DW, Beier F, Cai D. Early

changes of articular cartilage and subchondral bone in the DMM mouse model

of osteoarthritis. Sci Rep 2018 Feb 12;8(1):2855.

[30] Schuelert N, McDougall JJ. Electrophysiological evidence that the vasoactive

intestinal peptide receptor antagonist VIP6-28 reduces nociception in an

animal model of osteoarthritis. Osteoarthr Cartil 2006 Nov;14(11):1155e62.

Please cite this article as: Kanemitsu M et al., Role of vasoactive intestinal peptide in the progression of osteoarthritis through bone sclerosis and

angiogenesis in subchondral bone, Journal of Orthopaedic Science, https://doi.org/10.1016/j.jos.2019.11.010

...